Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis

We aimed to assess if GLP-1 agonists are associated with pancreatic cancer. Systematic review and meta-analysis of randomized trials with GLP-1 agonists as an intervention was performed. Trial sequential analysis (TSA) was performed to assess if the available information is sufficient to reject this...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Lana C., Falcetta, Mariana R., Rados, Dimitris V., Leitão, Cristiane B., Gross, Jorge L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382780/
https://www.ncbi.nlm.nih.gov/pubmed/30787365
http://dx.doi.org/10.1038/s41598-019-38956-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382780/
https://www.ncbi.nlm.nih.gov/pubmed/30787365
http://dx.doi.org/10.1038/s41598-019-38956-2

Ejemplares similares